tirzepatide muscle Weight loss and loss. The facts. GLP-1 drugs like semaglutide and produce impressive weight loss — but a consistent and underappreciated finding across trials is that a meaningful proportion of Tirzepatide‐induced body composition changes: Implications

Compounded GLP-1 medications occupy a regulatory gray zone that branded drugs like Ozempic and Wegovy do not

Protocol details: Initial phase dose: 20-30 ml per day Initial phase route: IV infusion (diluted in 100-250 ml saline) Initial duration: 14-21 days Maintenance dose: 10 ml per day Maintenance duration: 14 additional days Infusion time: 30-60 minutes (never rapid bolus at these doses) Expected timeline based on TBI trial data: Day 7-10: Improved neurological scores on GCS Day 21: Favorable GCS in treated patients with contusion and diffuse axonal injury Week 12: Significant cognitive improvement (CASI scores) in mild TBI Month 6: 67% achieved good outcomes (GOS 3-5) in moderate to severe cases Protocol 3: combination approach with donepezil Goal: Maximize cognitive benefit in established dementia through complementary mechanisms

Coachs Notes (The Dolce Takeaway) Coming off GLP-1s isnt a death sentence for your progressits a fork in the road

All Canadian customers are seen by Canadian providers who bring local clinical expertise and a deep understanding of the Canadian healthcare landscape